Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Coronaviruses
  4. Volume 6, Issue 1
  5. Article
Volume 6, Issue 1
  • ISSN: 2666-7967
  • E-ISSN: 2666-7975

Abstract

Introduction

COVID-19 is a global pandemic that has caused significant mortality. The disease severity varies among individuals, and the factors influencing its course remain unclear. This study aimed to investigate the influence of biochemical parameters and familial data on COVID-19 outcomes.

Methods

A retrospective analysis of 122 COVID-19 patients was conducted. Patients were categorized into two groups: outpatients with mild symptoms and those admitted to the intensive care unit (ICU) and intubated. Demographic data, biochemical levels of vitamin D, vitamin B12, and magnesium, and COVID-19 outcomes of first-, second-, and third-degree relatives were collected.

Results

The ICU group had a higher proportion of males (75%) and older patients (average age: 63.18±12.89 years) than the outpatient group (40% males and an average age of 45.13±13.77 years). Both groups had similar BMI, vitamin D, and vitamin B12 levels. However, magnesium levels were significantly higher in the ICU group (mean 2.25±0.3 mg/dL) than in the outpatient group (mean: 1.98±0.2 mg/dL). A significant familial relationship was identified between COVID-19 outcomes and disease course. Among the ICU patients, 25% had first-degree relatives who died from COVID-19, compared to only 10% of the outpatient patients. Similarly, second- and third-degree relatives of ICU patients had a higher mortality rate from COVID-19 than relatives of outpatient patients.

Conclusion

Age, gender, and magnesium levels may influence COVID-19 disease severity. Familial ties (genetic relatedness) may also play a role, suggesting potential genetic predisposition. Further research is needed to validate these findings and elucidate the underlying mechanisms.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/covid/10.2174/0126667975291444240209050447
2024-02-13
2025-01-06

  • From This Site

    /content/journals/covid/10.2174/0126667975291444240209050447
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. GuanW. NiZ. HuY. Clinical characteristics of coronavirus disease 2019 in China.N. Engl. J. Med.2020382181708172010.1056/NEJMoa2002032 32109013
     [Google Scholar]
  2. CaoY. LiuX. XiongL. CaiK. Imaging and clinical features of patients with 2019 novel coronavirus SARS‐CoV‐2: A systematic review and meta‐analysis.J. Med. Virol.20209291449145910.1002/jmv.25822 32242947
     [Google Scholar]
  3. CucinottaD. VanelliM. WHO declares COVID-19 a pandemic.Acta Biomed.202091115716010.23750/abm.v91i1.9397
     [Google Scholar]
  4. GorbalenyaA.E. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2.Nat. Microbiol.20205453654410.1038/s41564‑020‑0695‑z
     [Google Scholar]
  5. DrożdżalS. RosikJ. LechowiczK. An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment.Drug Resist. Updat.20215910079410.1016/j.drup.2021.100794 34991982
     [Google Scholar]
  6. NiknamZ. JafariA. GolchinA. Potential therapeutic options for COVID-19: An update on current evidence.Eur. J. Med. Res.2022271610.1186/s40001‑021‑00626‑3 35027080
     [Google Scholar]
  7. YangJ. HuJ. ZhuC. Obesity aggravates COVID‐19: A systematic review and meta‐analysis.J. Med. Virol.202193125726110.1002/jmv.26237 32603481
     [Google Scholar]
  8. HussainA. MahawarK. XiaZ. YangW. EL-Hasani S. RETRACTED: Obesity and mortality of COVID-19. Meta-analysis.Obes. Res. Clin. Pract.202014429530010.1016/j.orcp.2020.07.002 32660813
     [Google Scholar]
  9. HuangY. LuY. HuangY.M. Obesity in patients with COVID-19: A systematic review and meta-analysis.Metabolism202011315437810.1016/j.metabol.2020.154378 33002478
     [Google Scholar]
  10. SamM.L. When two pandemics meet: Why is obesity associated with increased COVID-19 mortality?Med2020113342
     [Google Scholar]
  11. ArulanandamB. BeladiH. ChakrabartiA. Obesity and COVID-19 mortality are correlated.Sci. Rep.2023131589510.1038/s41598‑023‑33093‑3 37041203
     [Google Scholar]
  12. News in Turkey,Coronavirus scientific committee meeting.2023Available from: https://www.medimagazin.com.tr/guncel/genel/tr-saglik-bakani-fahrettin-kocaenfekte-olan-7428-saglik-calisanimiz-var-11-681-88528.html (Accesed on 4 May 2023).
     [Google Scholar]
  13. World Health Organization.WHO Characterizes COVID-19 As a Pandemic.2020Available from: https://www.who.int/emergencies/diseases/novelcoronavirus-2019/events-as-they-happen (Accessed March 13, 2020).
    [Google Scholar]
  14. FlookM. JacksonC. VasileiouE. Informing the public health response to COVID-19: A systematic review of risk factors for disease, severity, and mortality.BMC Infect. Dis.202121134210.1186/s12879‑021‑05992‑1 33845766
     [Google Scholar]
  15. PijlsB.G. JolaniS. AtherleyA. Demographic risk factors for COVID-19 infection, severity, ICU admission and death: A meta-analysis of 59 studies.BMJ202111e04464010.1136/bmjopen‑2020‑044640
     [Google Scholar]
  16. AyoubH.H. ChemaitellyH. MumtazG.R. Characterizing key attributes of COVID-19 transmission dynamics in China’s original outbreak: Model-based estimations.Global Epidemiology2020210004210.1016/j.gloepi.2020.100042 33235991
     [Google Scholar]
  17. DaviesN.G. KlepacP. LiuY. Age-dependent effects in the transmission and control of COVID-19 epidemics.Nat. Med.20202681205121110.1038/s41591‑020‑0962‑9 32546824
     [Google Scholar]
  18. LiJ. HuangD.Q. ZouB. Epidemiology of COVID‐19: A systematic review and meta‐analysis of clinical characteristics, risk factors, and outcomes.J. Med. Virol.20219331449145810.1002/jmv.26424 32790106
     [Google Scholar]
  19. SzarpakL. RafiqueZ. GaseckaA. A systematic review and meta-analysis of effect of vitamin D levels on the incidence of COVID-19.Cardiol. J.202128564765410.5603/CJ.a2021.0072 34308537
     [Google Scholar]
  20. MunshiR. HusseinM.H. ToraihE.A. Vitamin D insufficiency as a potential culprit in critical COVID‐19 patients.J. Med. Virol.202193273374010.1002/jmv.26360 32716073
     [Google Scholar]
  21. WangH. ZhangJ. JiaL. ABO blood group influence COVID-19 infection: A meta-analysis.J. Infect. Dev. Ctries.202115121801180710.3855/jidc.13815 35044935
     [Google Scholar]
  22. AnnweilerC. BeaudenonM. GautierJ. COVID-19 and high-dose VITamin D supplementation TRIAL in high-risk older patients (COVIT-TRIAL): Study protocol for a randomized controlled trial.Trials2020211103110.1186/s13063‑020‑04928‑5 33371905
     [Google Scholar]
  23. TanC.W. HoL.P. KalimuddinS. Cohort study to evaluate the effect of vitamin D, magnesium, and vitamin B12 in combination on progression to severe outcomes in older patients with coronavirus (COVID-19).Nutrition202079-8011101710.1016/j.nut.2020.111017 33039952
     [Google Scholar]
  24. QuilliotD. BonsackO. JaussaudR. MazurA. Dysmagnesemia in COVID-19 cohort patients: Prevalence and associated factors.Magnes. Res.202033411412210.1684/mrh.2021.0476 33678604
     [Google Scholar]
  25. DarbeheshtiF. MahdiannasserM. UhalB.D. OginoS. GuptaS. RezaeiN. Interindividual immunogenic variants: Susceptibility to coronavirus, respiratory syncytial virus and influenza virus.Rev. Med. Virol.2021316e223410.1002/rmv.2234 33724604
     [Google Scholar]
  26. TraetsM.J.M. NijhuisR.H.T. MorréS.A. Association of genetic variations in ACE2, TIRAP and factor X with outcomes in COVID-19.PLoS One2022171e026089710.1371/journal.pone.0260897 34995294
     [Google Scholar]
  27. GrimaudoS. AmodioE. PipitoneR.M. PNPLA3 and TLL-1 polymorphisms as potential predictors of disease severity in patients with COVID-19.Front. Cell Dev. Biol.2021962791410.3389/fcell.2021.627914 34249902
     [Google Scholar]
  28. ChengW. HornungR. XuK. YangC. LiJ. Complement C3 identified as a unique risk factor for disease severity among young COVID-19 patients in Wuhan, China.Sci. Rep.2021111785710.1038/s41598‑021‑82810‑3 33846344
     [Google Scholar]
  29. RussoR. AndolfoI. LasorsaV.A. The TNFRSF13C H159Y variant is associated with severe COVID-19: A retrospective study of 500 patients from southern Italy.Genes202112688110.3390/genes12060881 34201032
     [Google Scholar]
  30. HubacekJ. DusekL. MajekO. CCR5Δ32 deletion as a protective factor in Czech first-wave COVID-19 subjects.Physiol. Res.202170111111510.33549/physiolres.934647 33728925
     [Google Scholar]
  31. KaselaS. DaniloskiZ. BollepalliS. Integrative approach identifies SLC6A20 and CXCR6 as putative causal genes for the COVID-19 GWAS signal in the 3p21.31 locus.Genome Biol.202122124210.1186/s13059‑021‑02454‑4 34425859
     [Google Scholar]
  32. JelinekH.F. MousaM. AlkaabiN. Allelic variants within the ABO blood group phenotype confer protection against critical COVID-19 hospital presentation.Front. Med.2022875964810.3389/fmed.2021.759648 35096865
     [Google Scholar]
  33. MohamedM.S. MoulinT.C. SchiöthH.B. Sex differences in COVID-19: The role of androgens in disease severity and progression.Endocrine20217113810.1007/s12020‑020‑02536‑6 33179220
     [Google Scholar]
  34. HashemiS.M.A. ThijssenM. HosseiniS.Y. TabarraeiA. PourkarimM.R. SarvariJ. Human gene polymorphisms and their possible impact on the clinical outcome of SARS-CoV-2 infection.Arch. Virol.202116682089210810.1007/s00705‑021‑05070‑6 33934196
     [Google Scholar]
/content/journals/covid/10.2174/0126667975291444240209050447
Loading
Biochemical and Familial Factors Influencing COVID-19 Disease Progression
Coronaviruses 6, e130224226939 (2025); https://doi.org/10.2174/0126667975291444240209050447
/content/journals/covid/10.2174/0126667975291444240209050447
/content/journals/covid/10.2174/0126667975291444240209050447
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): biochemical parameters; COVID-19; disease severity; familial data; genetic predisposition; viral pneumonia
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test